Stock listing

A2QLX7 Stock Price, News, Filings & Events — Zevra Therapeutics, Inc.

Selected listing: A2QLX7 · LSX · EUR · DE

A2QLX7:LSX is the listing for Zevra Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies for rare diseases. The company is actively engaged in advancing its pipeline and has recently made updates regarding its clinical trials and regulatory filings. Investors can find relevant news, financial reports, and upcoming events that may impact the company's performance and market position. The context of the biopharmaceutical sector and ongoing developments in rare disease treatments are also pertinent to understanding Zevra's strategic direction.

A2QLX7:LSXEURDEUpdated July 31, 2026
Zevra Therapeutics, Inc. logo
Ticker
A2QLX7:LSX
Asset type
Stock
Market cap
$562.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSX
Currency
EUR

Zevra Therapeutics, Inc. A2QLX7:LSX stock context

A2QLX7:LSX is the listing for Zevra Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies for rare diseases. The company is actively engaged in advancing its pipeline and has recently made updates regarding its clinical trials and regulatory filings. Investors can find relevant news, financial reports, and upcoming events that may impact the company's performance and market position. The context of the biopharmaceutical sector and ongoing developments in rare disease treatments are also pertinent to understanding Zevra's strategic direction.

Research Zevra Therapeutics, Inc.

Alternate listings